Medical News

---

• Stressful life events linked to increased asthma risk
• Diagnostic shift common after FEP
• Neurological soft signs linked to brain structure alterations in schizophrenia
• Elevated gas6 levels may increase VTE risk
• OAC likely to benefit all AF patients with coronary stents
• Prostate cancer drug shows promise against bone metastasis
• Prostate cancer drug shows promise against bone metastasis
• <b>FDA warns against use of high-dose simvastatin</b>
• <b>Researchers question effect of FH-associated mutations on carotid atherosclerosis</b>
• Diabetes has ‘profound negative impact’ on working life
• HbA1c predicts future diabetes risk

Stressful life events linked to increased asthma risk Posted: 09 Jun 2011 05:00 PM PDT Stressful life events, such as illness in a family member and divorce, are associated with an increased risk for asthma, results from a Finnish study suggest.

Diagnostic shift common after FEP Posted: 09 Jun 2011 05:00 PM PDT Around a fifth of patients who have suffered a first episode of psychosis have their diagnosis changed at the time of recurrence, research shows.

Neurological soft signs linked to brain structure alterations in schizophrenia Posted: 09 Jun 2011 05:00 PM PDT Structural alterations in the cerebello-thalamo-prefrontal network are associated with neurological soft signs in patients with schizophrenia, research shows.

Elevated gas6 levels may increase VTE risk Posted: 08 Jun 2011 05:00 PM PDT Canadian researchers have shown that patients with high levels of the growth arrest-specific 6 protein have a considerably increased risk for venous thromboembolism.

OAC likely to benefit all AF patients with coronary stents Posted: 08 Jun 2011 05:00 PM PDT MedWire News: Patients with atrial fibrillation (AF) who have undergone coronary stenting are at high risk for stroke and thromboembolism even if they have a low CHADS2 score, research suggests.

Prostate cancer drug shows promise against bone metastasis Posted: 08 Jun 2011 05:00 PM PDT Novel prostate cancer drug particularly effective for preventing bone metastasis in advanced stage patients, report US researchers.

Prostate cancer drug shows promise against bone metastasis Posted: 08 Jun 2011 05:00 PM PDT Novel prostate cancer drug particularly effective for preventing bone metastasis in advanced stage patients, report US researchers.

<b>FDA warns against use of high-dose simvastatin</b> Posted: 08 Jun 2011 05:00 PM PDT The US Food and Drug Administration has announced new safety recommendations for high-dose simvastatin.

<b>Researchers question effect of FH-associated mutations on carotid atherosclerosis</b> Posted: 08 Jun 2011 05:00 PM PDT Dutch researchers say that the risk for cardiovascular disease in patients with familial hypercholesterolemia may, to a large extent, be related to levels of low-density lipoprotein cholesterol and not directly to the presence of a mutation

Diabetes has ‘profound negative impact’ on working life Posted: 08 Jun 2011 05:00 PM PDT Results from a large French prospective study suggest that diabetes has a significant negative effect on workforce participation.

HbA1c predicts future diabetes risk Posted: 08 Jun 2011 05:00 PM PDT Glycated hemoglobin levels can predict risk for future Type 2 diabetes, although not as strongly as 1-hour plasma glucose concentrations, suggest study results.

You are subscribed to email updates from MedWire Medical News Combined Feed To stop receiving these emails, you may unsubscribe now.	Email delivery powered by Google
Google Inc., 20 West Kinzie, Chicago IL USA 60610